图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
免疫学评论综述™
影响因子: 1.404 5年影响因子: 3.347 SJR: 0.706 SNIP: 0.55 CiteScore™: 2.19

ISSN 打印: 1040-8401
ISSN 在线: 2162-6472

免疫学评论综述™

DOI: 10.1615/CritRevImmunol.v20.i1.40
4 pages

Chronic Allograft Rejection Associated Vasculopathy and Synthetic Biodegradable Vascular Grafts: A Lesson to Learn?

Paul Nieuwenhuis
Department of Histology and Cell Biology, Faculty of Medical Sciences, University of Groningen, Oostersingel 69-1, 9713 EZ Groningen, the Netherlands
Jan-Luuk Hillebrands
Department of Histology and Cell Biology, Faculty of Medical Sciences, University of Groningen, Oostersingel 69-1, 9713 EZ Groningen, the Netherlands
Jan Rozing
Department of Histology and Cell Biology, Faculty of Medical Sciences, University of Groningen, Oostersingel 69-1, 9713 EZ Groningen, the Netherlands

ABSTRACT

In chronic allograffs, graft vessels eventually develop so-called "transplant vascular sclerosis" or "intimal hyperplasia". A major question is whether the cells in the neointima are donor or recipient derived. The process of transplant vascular sclerosis closely resembles the remodeling of the vascular wall as seen when synthetic biodegradable small caliber vascular grafts are implanted. In this model, the cells in the newly developing neointima as well as neomedia are, by definition, recipient derived.
By using cardiac allografts as well as aortic allografts exchanged between a female donor and a male recipient (rats), the origin of the neointimal vascular smooth muscle cells could be traced by looking for the Y-chromosome in isolated (α-actin positive) intimal cells using PCR. In both models these intimal cells were found to be of recipient-origin.
It is proposed, that, basically, this remodeling process is part of a normal healing process. Whereas in biodegradable grafts this "healing process" appears to be self limiting, in allografts the process goes on beyond the needs of functional repair, eventually, in some cases, leading to total vascular occlusion. Future therapeutic protocols might try and aim at controlling this essentially normal repair process.


Articles with similar content:

Regulatory Mechanisms in Vascular Calcification
Critical Reviews™ in Eukaryotic Gene Expression, Vol.10, 2000, issue 2
Linda L. Demer, Kristina Bostrom
The Basis of Immunogenicity of Endocrine Allografts
Critical Reviews™ in Immunology, Vol.21, 2001, issue 1-3
Ronald G. Gill, Marilyne Coulombe, Mark R. Nicolls
Approaches for Skeletal Gene Therapy
Critical Reviews™ in Eukaryotic Gene Expression, Vol.12, 2002, issue 3
Paul D. Robbins, Christopher Niyibizi, Corey J. Wallach, Zhibao Mi
Compartmentalization g/d T Cells and Their Putative Role in Mucosal Immunity
Critical Reviews™ in Immunology, Vol.23, 2003, issue 5-6
Wolfgang Holtmeier
Human Leukemia-derived Dendritic Cells: Ex-vivo Development of Specific Antileukemic Cytotoxicity
Critical Reviews™ in Immunology, Vol.18, 1998, issue 1-2
Dominique Charron, Richard E. Champlin, Aniruddha Choudhury, David F. Claxton, Antoine Toubert, Sapna Sutaria